Personal information

Other IDs

Loop profile: 403562

Keywords

Tuberculosis, Infectious Diseases, Public Health, Epidemiology, HIV/AIDS, Malaria, Surveillance

Activities

Collapse all

Employment (10)

Hospital Municipal de Badalona: Badalona, Catalunya, ES

Médico de Urgencias
Employment
Source: Self-asserted source
Joan Pau Millet

Grup Mutua Terrassa: Terrassa, Catalunya, ES

Adjunto de Medicina CAP Terrassa Sud
Employment
Source: Self-asserted source
Joan Pau Millet

Grup Mutua Terrassa: Terrassa, Catalunya, ES

Guardias ambulatorias
Employment
Source: Self-asserted source
Joan Pau Millet

Agència de salut pública de barcelona: Barcelona, ES

2018-04-01 to present (Servei d'Epidemiologia)
Employment
Source: Self-asserted source
Joan Pau Millet

Servicios Clinicos: Barcelona, ES

2014-12-01 to present
Employment
Source: Self-asserted source
Joan Pau Millet

Fundacion catalana de neumologia: Barcelona, ES

2009-01-01 to 2017-09-17
Employment
Source: Self-asserted source
Joan Pau Millet

Institut Catala De La Salut: Barcelona, Catalunya, ES

2007 to 2014 | Adjunto de Urgencias
Employment
Source: Self-asserted source
Joan Pau Millet

CIBER de Epidemiología y Salud Pública: Barcelona, ES

2007 to 2008-12 | Investigador
Employment
Source: Self-asserted source
Joan Pau Millet

Fundacion Vicente Ferrer: Anantapur, IN

2005-02 to 2005-05 | Médico Hospital de Bathalapalli. India
Employment
Source: Self-asserted source
Joan Pau Millet

Médicos Sin Fronteras: Barcelona, Catalunya, ES

2004-03 to 2004-09 | Médico de Terreno en RD Congo
Employment
Source: Self-asserted source
Joan Pau Millet

Education and qualifications (4)

Universitat Pompeu Fabra: Barcelona, Catalunya, ES

Master de Salud Publica
Education
Source: Self-asserted source
Joan Pau Millet

Universitat Autònoma de Barcelona Facultat de Medicina: Bellaterra, Catalunya, ES

Master de Medicina Tropical y Salud Internacional
Education
Source: Self-asserted source
Joan Pau Millet

Universitat Autònoma de Barcelona: Bellaterra, Catalunya, ES

Doctorado en Salud Publica y Metodología de la Investigación Biomédica
Education
Source: Self-asserted source
Joan Pau Millet

Grup Mutua Terrassa: Terrassa, Catalunya, ES

1999-06-01 to 2002-05-31 | Especialista en Medicina Familiar y Comunitaria
Education
Source: Self-asserted source
Joan Pau Millet

Works (28)

Exposure Time to a Tuberculosis Index Case as a Marker of Infection in Immigrant Populations

Pathogens
2025-02 | Journal article | Author
DOI: 10.3390/pathogens14020175
Contributors: Sofia Godoy; Miquel Alsedà; Ignacio Parron; Joan Pau Millet; Joan A. Caylà; Núria Follia; Monica Carol; Angels Orcau; D Toledo; Gloria Ferrús et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Factors Associated with Non-Adherence to Tuberculosis Preventive Treatment among Adult Contacts of Pulmonary Tuberculosis Cases with Latent Tuberculosis Infection in Catalonia, Spain, in 2019−2021

Tropical Medicine and Infectious Disease
2024-02 | Journal article | Author
DOI: 10.3390/tropicalmed9030054
Contributors: Pedro Plans-Rubió; Sofia Godoy; D Toledo; Angela Domínguez; Joan A. Caylà; Ignacio Parron; Joan Pau Millet; Pere Godoy
Source: check_circle
Multidisciplinary Digital Publishing Institute

Factors Associated with Treatment Prescription to Pulmonary Tuberculosis Contacts in Catalonia (2019–2021): A Population-Based Epidemiological Study

Vaccines
2023-12 | Journal article | Author
DOI: 10.3390/vaccines11121800
Contributors: Domínguez A; Núria Soldevila; D Toledo; Ignacio Parron; Joan Pau Millet; Irene Barrabeig; Pere Godoy; on behalf of Transmission of Tuberculosis in Catalonia (Spain) Working Group
Source: check_circle
Multidisciplinary Digital Publishing Institute

Losses in the Care Cascade for Latent Tuberculosis Infection in the Tracing Contact Studies

Pathogens
2023-11 | Journal article | Author
DOI: 10.3390/pathogens12121403
Contributors: Sofia Godoy; Ignacio Parron; Joan Pau Millet; Joan A. Caylà; Núria Follia; Mònica Carol; Àngels Orcau; Miquel Alsedà; D Toledo; Glòria Ferrús et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Epidemiology of Tuberculosis in Immigrants in a Large City with Large-Scale Immigration (1991-2013).

2016 | Journal article
DOI: 10.1371/journal.pone.0164736
PMID: 27749904
PMC: PMC5066941
Contributors: Ospina JE; Orcau À; Millet JP; Ros M; Gil S; Caylà JA; Barcelona Tuberculosis Immigration Working Group
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment.

2016 | Journal article
DOI: 10.1371/journal.pone.0159925
PMID: 27487189
PMC: PMC4972388
Contributors: Rodrigo T; Casals M; Caminero JA; García-García JM; Jiménez-Fuentes MA; Medina JF; Millet JP; Ruiz-Manzano J; Caylá J; Working Group of the Integrated Programme of Tuberculosis Research
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.

2016-03 | Journal article
DOI: 10.1016/s2352-3018(15)00252-0
PMID: 26939735
Contributors: Podlekareva DN; Efsen AM; Schultze A; Post FA; Skrahina AM; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J et al.
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.

2015-09 | Journal article
DOI: 10.5588/ijtld.14.0829
PMID: 26260821
PMC: PMC5080618
Contributors: Bliven-Sizemore EE; Sterling TR; Shang N; Benator D; Schwartzman K; Reves R; Drobeniuc J; Bock N; Villarino ME; TB Trials Consortium
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.

2015-03 | Journal article
DOI: 10.1001/jamapediatrics.2014.3158
PMID: 25580725
Contributors: Villarino ME; Scott NA; Weis SE; Weiner M; Conde MB; Jones B; Nachman S; Oliveira R; Moro RN; Shang N et al.
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

[Potentially excluded population from health coverage and health impact since Royal Decree 16/2012: The Central Catalonia experience].

2015-01 | Journal article
DOI: 10.1016/j.aprim.2014.03.014
PMID: 25241354
Contributors: Álamo-Junquera D; Sala N; Millet JP; Ortega-Gutiérrez L; Planas-Giner A; Rovira C; Comet D
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe.

2014-01 | Journal article
DOI: 10.1183/09031936.00138712
PMID: 23766333
Contributors: Podlekareva DN; Panteleev AM; Grint D; Post FA; Miro JM; Bruyand M; Furrer H; Obel N; Girardi E; Vasilenko A et al.
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse?

2013 | Journal article
DOI: 10.1371/journal.pone.0064898
PMID: 23776440
PMC: PMC3679149
Contributors: Millet JP; Shaw E; Orcau A; Casals M; Miró JM; Caylà JA; Barcelona Tuberculosis Recurrence Working Group
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Factors that influence current tuberculosis epidemiology.

2013-06 | Journal article
DOI: 10.1007/s00586-012-2334-8
PMID: 22565801
PMC: PMC3691414
Contributors: Millet JP; Moreno A; Fina L; del Baño L; Orcau A; de Olalla PG; Caylà JA
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Recurrences in tuberculosis in a cohort of human immunodeficiency virus-infected patients: the influence of highly active antiretroviral therapy.

2013-04 | Journal article
DOI: 10.1016/j.eimc.2012.08.008
PMID: 23219687
Contributors: Millet JP; Orcau A; Casals M; Garcia de Olalla P; Caylà JA
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients.

2013-02 | Journal article
DOI: 10.5588/ijtld.12.0224
PMID: 23317955
Contributors: Podlekareva DN; Grint D; Post FA; Mocroft A; Panteleev AM; Miller RF; Miro JM; Bruyand M; Furrer H; Riekstina V et al.
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Community health workers improve contact tracing among immigrants with tuberculosis in Barcelona.

2012 | Journal article
DOI: 10.1186/1471-2458-12-158
PMID: 22394990
PMC: PMC3312853
Contributors: Ospina JE; Orcau A; Millet JP; Sánchez F; Casals M; Caylà JA
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.

2012-10 | Journal article
DOI: 10.1093/infdis/jis461
PMID: 22850121
Contributors: Dorman SE; Goldberg S; Stout JE; Muzanyi G; Johnson JL; Weiner M; Bozeman L; Heilig CM; Feng PJ; Moro R et al.
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Incidence of infectious diseases and survival among the Roma population: a longitudinal cohort study.

2012-04 | Journal article
DOI: 10.1093/eurpub/ckq204
PMID: 21217119
Contributors: Casals M; Pila P; Langohr K; Millet JP; Caylà JA; Roma Population Working Group
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Epidemiology of imported malaria among children and young adults in Barcelona (1990-2008).

2011 | Journal article
DOI: 10.1186/1475-2875-10-347
PMID: 22118531
PMC: PMC3250960
Contributors: Garcia-Villarrubia M; Millet JP; de Olalla PG; Gascón J; Fumadó V; i Prat JG; Treviño B; Pinazo MJ; Cabezos J; Muñoz J et al.
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Predictors of death among patients who completed tuberculosis treatment: a population-based cohort study.

2011 | Journal article
DOI: 10.1371/journal.pone.0025315
PMID: 21980423
PMC: PMC3182201
Contributors: Millet JP; Orcau A; Rius C; Casals M; de Olalla PG; Moreno A; Nelson JL; Caylà JA; Barcelona Tuberculosis Working Group
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Three months of rifapentine and isoniazid for latent tuberculosis infection.

2011-12 | Journal article
DOI: 10.1056/nejmoa1104875
PMID: 22150035
Contributors: Sterling TR; Villarino ME; Borisov AS; Shang N; Gordin F; Bliven-Sizemore E; Hackman J; Hamilton CD; Menzies D; Kerrigan A et al.
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment.

2011-02 | Journal article
PMID: 21219692
Contributors: Català L; Orcau A; García de Olalla P; Millet JP; Rodríguez-Mondragón A; Caylà JA; TB-HIV Working Group
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

[On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagació en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention].

2010 | Journal article
DOI: 10.1016/j.gaceta.2009.08.008
PMID: 20005019
Contributors: Moreno A; Sánchez F; Nelson J; Miró JM; Caylà JA; Grupo de Trabajo de la UITB-TBTC (site 31)
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Transmission Of childhood tuberculosis risk factors associated with an unidentified index case and outbreak evolution in Barcelona (1987-2007).

2010-09 | Journal article
DOI: 10.1097/inf.0b013e3181de750d
PMID: 20806481
Contributors: Nelson JL; Moreno A; Orcau A; Altet N; Martínez-Roig A; Cayla JA; Casals M; Millet JP; Moraga-Llop F; Childhood Tuberculosis Working Group of Barcelona
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Imported malaria among African immigrants: is there still a relationship between developed countries and their ex-colonies?

2009 | Journal article
DOI: 10.1186/1475-2875-8-111
PMID: 19463171
PMC: PMC2693516
Contributors: Millet JP; de Olalla PG; Gascón J; Prat JG; Treviño B; Pinazo MJ; Cabezos J; Muñoz J; Zarzuela F; Caylà JA
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Tuberculosis recurrence and its associated risk factors among successfully treated patients.

2009-10 | Journal article
DOI: 10.1136/jech.2008.077560
PMID: 19179367
Contributors: Millet JP; Orcau A; de Olalla PG; Casals M; Rius C; Caylà JA
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Imported malaria in a cosmopolitan European city: a mirror image of the world epidemiological situation.

2008 | Journal article
DOI: 10.1186/1475-2875-7-56
PMID: 18397524
PMC: PMC2362124
Contributors: Millet JP; Garcia de Olalla P; Carrillo-Santisteve P; Gascón J; Treviño B; Muñoz J; Gómez I Prat J; Cabezos J; González Cordón A; Caylà JA
Source: Self-asserted source
Joan Pau Millet via Europe PubMed Central

Factors Associated with Non-Adherence to Tuberculosis Pre-ventive Treatment among Adult Contacts of Pulmonary Tuberculosis Cases with Latent Tuberculosis Infection in Catalonia, Spain, in 2019−2021
Source: check_circle
Multidisciplinary Digital Publishing Institute

Peer review (1 review for 1 publication/grant)

Review activity for PloS one. (1)
How many people are using ORCID?